Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Vehicle-controlled, Safety and Efficacy Study of EVO101 in Adult Subjects With Atopic Dermatitis

NCT05579899 is registered in ClinicalTrials.gov with Evommune, Inc. as lead sponsor.

NCT NCT05579899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05579899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Vehicle-controlled, Safety and Efficacy Study of EVO101 in Adult Subjects With Atopic Dermatitis
Lead sponsor
Evommune, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 27, 2022
Completion date
July 27, 2023
Enrollment
119 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis eczema